TOURMALINE BIO INC (TRML) Stock Cash Flow
NASDAQ:TRML - Nasdaq - US89157D1054 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -73.21M | -42.12M | -73.89M | -47.83M | -22.71M | |||
| Depreciation Amortization | 39.00K | 33.00K | 1.38M | 620.00K | 450.00K | |||
| Change In Working Capital | -3.15M | -168.00K | 1.10M | 2.32M | 1.61M | |||
| Other non cash items | -938.00K | 14.18M | 10.56M | 4.91M | 1.43M | |||
| OPERATING CASH FLOW | -77.26M | -28.08M | -60.86M | -39.99M | -19.21M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -9.00K | -56.00K | -3.04M | -2.44M | -1.29M | |||
| Other Investing Activity | -194.30M | 3.90M | 58.71M | -93.95M | -132.01M | |||
| INVESTING CASH FLOW | -194.31M | 3.84M | 55.67M | -96.39M | -133.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 0.00 | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | -4.00K | 91.97M | 240.00K | 137.68M | 131.12M | |||
| Other Financing Activity | 161.35M | 64.75M | 0.00 | -280.00K | N/A | |||
| FINANCING CASH FLOW | 161.35M | 156.72M | 240.00K | 137.40M | 131.12M | |||
| CHANGE IN CASH | -110.22M | 132.48M | -4.95M | 1.02M | -21.39M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -77.26M | -28.08M | -60.86M | -39.99M | -19.21M | |||
| Capital Expenditure | -9.00K | -56.00K | -3.04M | -2.44M | -1.29M | |||
| FREE CASH FLOW | -77.27M | -28.14M | -63.90M | -42.43M | -20.50M | |||
All data in USD